lauric acid has been researched along with Glaucoma in 1 studies
dodecanoic acid : A straight-chain, twelve-carbon medium-chain saturated fatty acid with strong bactericidal properties; the main fatty acid in coconut oil and palm kernel oil.
Glaucoma: An ocular disease, occurring in many forms, having as its primary characteristics an unstable or a sustained increase in the intraocular pressure which the eye cannot withstand without damage to its structure or impairment of its function. The consequences of the increased pressure may be manifested in a variety of symptoms, depending upon type and severity, such as excavation of the optic disk, hardness of the eyeball, corneal anesthesia, reduced visual acuity, seeing of colored halos around lights, disturbed dark adaptation, visual field defects, and headaches. (Dictionary of Visual Science, 4th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| " Low bioavailability and high frequency of administration in eye drops are major challenges in ocular pharmacotherapy." | 5.91 | Synthesis and evaluation of modified lens using plasma treatment containing timolol-maleate loaded lauric acid-decorated chitosan-alginate nanoparticles for glaucoma. ( Alemezadeh, SA; Bagherzadeh, K; Hosseini, MS; Mehravi, B; Mirzaei, M; Mohseni, M; Naseripour, M, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hosseini, MS | 1 |
| Mohseni, M | 1 |
| Naseripour, M | 1 |
| Mirzaei, M | 1 |
| Bagherzadeh, K | 1 |
| Alemezadeh, SA | 1 |
| Mehravi, B | 1 |
1 other study available for lauric acid and Glaucoma
| Article | Year |
|---|---|
Synthesis and evaluation of modified lens using plasma treatment containing timolol-maleate loaded lauric acid-decorated chitosan-alginate nanoparticles for glaucoma.
Topics: Chitosan; Drug Delivery Systems; Glaucoma; Humans; Maleates; Nanoparticles; Ophthalmic Solutions; Ti | 2023 |